Literature DB >> 5132586

Effects of L-dopa alone and in combination with dopa decarboxylase inhibitors on the arterial pressure and heart rate of dogs.

D H Minsker, A Scriabine, A L Stokes, C A Stone, M L Torchiana.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5132586     DOI： 10.1007/BF02147580

Source DB:  PubMed          Journal:  Experientia        ISSN： 0014-4754


× No keyword cloud information.
  16 in total

1.  Central hypotensive effect of L-3,4-dihydroxyphenylalanine in the rat.

Authors:  M Henning; A Rubenson
Journal:  J Pharm Pharmacol       Date:  1970-08       Impact factor: 3.765

2.  Effect of various decarboxylase inhibitors on the cerebral metabolism of dihydroxyphenylalanine.

Authors:  G Bartholini; A Pletscher
Journal:  J Pharm Pharmacol       Date:  1969-05       Impact factor: 3.765

3.  Evidence for a centrally mediated hypotensive effect of L-dopa in the rat.

Authors:  M Henning; A Rubenson
Journal:  J Pharm Pharmacol       Date:  1970-03       Impact factor: 3.765

4.  Modification of Parkinsonism--chronic treatment with L-dopa.

Authors:  G C Cotzias; P S Papavasiliou; R Gellene
Journal:  N Engl J Med       Date:  1969-02-13       Impact factor: 91.245

5.  On the significance of central noradrenaline for motor activity: experiments with a new dopamine beta-hydroxylase inhibitor.

Authors:  T H Svensson; B Waldeck
Journal:  Eur J Pharmacol       Date:  1969-09       Impact factor: 4.432

6.  [The capillary barrier for dopa in brain and different organs].

Authors:  J Constantinidis; J C De La Torre; R Tissot; F Geissbuhler
Journal:  Psychopharmacologia       Date:  1969

7.  [Potentiation of the central effect of DOPA after selective inhibition of extracerebral decarboxylase].

Authors:  J M Gaillard; R Schaeppi; R Tissot
Journal:  Arch Int Pharmacodyn Ther       Date:  1969-08

8.  Treatment of parkinsonism with levodopa.

Authors:  M D Yahr; R C Duvoisin; M J Schear; R E Barrett; M M Hoehn
Journal:  Arch Neurol       Date:  1969-10

9.  The localization of monoaminergic blood-brain barrier mechanisms.

Authors:  A Bertler; B Falck; C Owman; E Rosengrenn
Journal:  Pharmacol Rev       Date:  1966-03       Impact factor: 25.468

10.  Hypotension caused by L-dopa.

Authors:  D B Calne; J Brennan; A S Spiers; G M Stern
Journal:  Br Med J       Date:  1970-02-21
View more
  5 in total

1.  Successful perioperative management of patients with Parkinson's disease following gastrointestinal surgery: report of three cases.

Authors:  Takaaki Fujii; Toshihiro Nakabayashi; Shinji Hashimoto; Hiroyuki Kuwano
Journal:  Surg Today       Date:  2009-09-24       Impact factor: 2.549

Review 2.  Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1971       Impact factor: 9.546

3.  An analysis of the peripheral effects of l-DOPA on autonomic nerve function.

Authors:  M J Antonaccio; R D Robson
Journal:  Br J Pharmacol       Date:  1974-09       Impact factor: 8.739

4.  Aterial blood pressure in dogs: effects of m-tyrosine alone or in combination with inhibitors of aromatic amino acid decarboxylase; relative hypotensive potencies of L-dopa, DL-m-tyrosine, and L-m-tyrosine.

Authors:  D H Minsker; A L Stokes
Journal:  Experientia       Date:  1974-09-15

5.  On the mechanism of L-dopa-induced postural hypotension in the cat.

Authors:  K M Dhasmana; B A Spilker
Journal:  Br J Pharmacol       Date:  1973-03       Impact factor: 8.739
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.